To include your compound in the COVID-19 Resource Center, submit it here.

Glycopyrrolate: Phase III data

The double-blind, U.S. Phase III GOLDEN-3 and GOLDEN-4 trials in patients ages >=40 with moderate to very severe

Read the full 188 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE